Therapix Biosciences (NASDAQ:TRPX) is developing cannabinoid -based treatments for Tourette Syndrome and mild cognitive impairment.
Therapix Biosciences (NASDAQ:TRPX) is developing cannabinoid -based treatments for Tourette Syndrome and mild cognitive impairment.